Hetero Enters Into a Licensing Agreement With Gilead Sciences,...
HYDERABAD, India, May 14, 2020 /PRNewswire-AsiaNet/ -- Hetero, one of India's leading generic pharmaceutical companies and the world's largest producer of anti-retroviral drugs, announced today that it has entered into a licensing agreement with Gilead Sciences, Inc. for the manufacturing and distribu...
Authors: LATEST ASIANET NEWS RELEASES